コンテンツへスキップ
Merck
  • Novel hypoglycemic injury mechanism: N-methyl-D-aspartate receptor-mediated white matter damage.

Novel hypoglycemic injury mechanism: N-methyl-D-aspartate receptor-mediated white matter damage.

Annals of neurology (2013-11-19)
Xin Yang, Margaret A Hamner, Angus M Brown, Richard D Evans, Zu-Cheng Ye, Shengdi Chen, Bruce R Ransom
要旨

Hypoglycemia is a common adverse event and can injure central nervous system (CNS) white matter (WM). We determined whether glutamate receptors were involved in hypoglycemic WM injury. Mouse optic nerves (MON), CNS WM tracts, were maintained at 37°C with oxygenated artificial cerebrospinal fluid (ACSF) containing 10mM glucose. Aglycemia was produced by switching to 0 glucose ACSF. Supramaximal compound action potentials (CAPs) were elicited using suction electrodes, and axon function was quantified as the area under the CAP. Amino acid release was measured using high-performance liquid chromatography. Extracellular lactate concentration ([lactate(-)]o) was measured using an enzyme electrode. About 50% of MON axons were injured after 60 minutes of aglycemia (90% after 90 minutes); injury extent was not affected by animal age. Blockade of N-methyl-D-aspartate (NMDA)-type glutamate receptors improved recovery after 90 minutes of aglycemia by 250%. Aglycemic injury was increased by reducing [Mg(2+)]o or increasing [glycine]o , and decreased by lowering pHo , expected results for NMDA receptor-mediated injury. pHo increased during aglycemia due to a drop in [lactate(-)]o. Aglycemic injury was dramatically reduced in the absence of [Ca(2+)]o. Extracellular aspartate, a selective NMDA receptor agonist, increased during aglycemia ([glutamate]o fell). Aglycemia injured WM by a unique excitotoxic mechanism involving NMDA receptors (located primarily on oligodendrocytes). During WM aglycemia, the selective NMDA agonist aspartate is released, probably from astrocytes. Injury is mediated by Ca(2+) influx through aspartate-activated NMDA receptors made permeable by an accompanying alkaline shift in pHo caused by a fall in [lactate(-)]o. These insights have important clinical implications.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
グリシン, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
グリシン, suitable for electrophoresis, ≥99%
Sigma-Aldrich
グリシン, BioUltra, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
L-アスパラギン酸, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
キヌレン酸, ≥98%
Sigma-Aldrich
グリシン, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
SAFC
グリシン
Sigma-Aldrich
グリシン 塩酸塩, ≥99% (HPLC)
Sigma-Aldrich
L-アスパラギン酸, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
グリコーゲン from oyster
Sigma-Aldrich
グリコーゲン ウシ肝臓由来, ≥85% dry basis (enzymatic)
USP
グリシン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
L-アスパラギン酸, BioXtra, ≥99% (HPLC)
Sigma-Aldrich
イガイ属ムール貝由来グリコーゲン Mytilus edulis(ムラサキイガイ)由来, for DNA precipitations
Sigma-Aldrich
グリシン, BioXtra, ≥99% (titration)
Sigma-Aldrich
L-アスパラギン酸 カリウム塩, ≥98% (HPLC)
Sigma-Aldrich
L-アスパラギン酸, BioUltra, ≥99.5% (T)
Sigma-Aldrich
1 Mグリシン 溶液
Sigma-Aldrich
DL-アスパラギン酸, ≥99% (TLC)
Sigma-Aldrich
グリコーゲン from rabbit liver, ≥85% dry basis (enzymatic)
SAFC
L-アスパラギン酸
Sigma-Aldrich
グリシン, 99%, FCC
Sigma-Aldrich
イガイ属ムール貝由来グリコーゲン Mytilus edulis(ムラサキイガイ)由来, ≥85% anhydrous basis (enzymatic)
Sigma-Aldrich
NBQX 二ナトリウム塩 水和物, ≥98% (HPLC)
Sigma-Aldrich
グリシン, SAJ special grade, ≥99.0%
Sigma-Aldrich
グリシン, ACS reagent, ≥98.5%
Sigma-Aldrich
(±)-AMPA, solid
Sigma-Aldrich
(S)-AMPA, ≥97%
Supelco
グリシン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
グリシン, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)